S&P 500   3,452.67 (+0.75%)
DOW   28,381.70 (+0.66%)
QQQ   285.36 (+0.55%)
AAPL   117.12 (+0.98%)
MSFT   216.51 (+1.07%)
FB   266.34 (+1.89%)
GOOGL   1,545.66 (+1.03%)
AMZN   3,231.72 (+0.76%)
TSLA   422.80 (-1.86%)
NVDA   546.34 (+1.19%)
BABA   309.84 (+1.49%)
CGC   18.94 (-4.39%)
GE   7.31 (+0.27%)
MU   53.32 (+1.31%)
AMD   82.13 (+0.16%)
T   26.86 (-0.07%)
F   7.72 (+1.71%)
ACB   4.31 (-8.49%)
GILD   60.18 (-0.64%)
NFLX   526.50 (-0.80%)
BA   166.66 (-0.27%)
BAC   24.05 (+1.39%)
DIS   124.53 (+0.24%)
S&P 500   3,452.67 (+0.75%)
DOW   28,381.70 (+0.66%)
QQQ   285.36 (+0.55%)
AAPL   117.12 (+0.98%)
MSFT   216.51 (+1.07%)
FB   266.34 (+1.89%)
GOOGL   1,545.66 (+1.03%)
AMZN   3,231.72 (+0.76%)
TSLA   422.80 (-1.86%)
NVDA   546.34 (+1.19%)
BABA   309.84 (+1.49%)
CGC   18.94 (-4.39%)
GE   7.31 (+0.27%)
MU   53.32 (+1.31%)
AMD   82.13 (+0.16%)
T   26.86 (-0.07%)
F   7.72 (+1.71%)
ACB   4.31 (-8.49%)
GILD   60.18 (-0.64%)
NFLX   526.50 (-0.80%)
BA   166.66 (-0.27%)
BAC   24.05 (+1.39%)
DIS   124.53 (+0.24%)
S&P 500   3,452.67 (+0.75%)
DOW   28,381.70 (+0.66%)
QQQ   285.36 (+0.55%)
AAPL   117.12 (+0.98%)
MSFT   216.51 (+1.07%)
FB   266.34 (+1.89%)
GOOGL   1,545.66 (+1.03%)
AMZN   3,231.72 (+0.76%)
TSLA   422.80 (-1.86%)
NVDA   546.34 (+1.19%)
BABA   309.84 (+1.49%)
CGC   18.94 (-4.39%)
GE   7.31 (+0.27%)
MU   53.32 (+1.31%)
AMD   82.13 (+0.16%)
T   26.86 (-0.07%)
F   7.72 (+1.71%)
ACB   4.31 (-8.49%)
GILD   60.18 (-0.64%)
NFLX   526.50 (-0.80%)
BA   166.66 (-0.27%)
BAC   24.05 (+1.39%)
DIS   124.53 (+0.24%)
S&P 500   3,452.67 (+0.75%)
DOW   28,381.70 (+0.66%)
QQQ   285.36 (+0.55%)
AAPL   117.12 (+0.98%)
MSFT   216.51 (+1.07%)
FB   266.34 (+1.89%)
GOOGL   1,545.66 (+1.03%)
AMZN   3,231.72 (+0.76%)
TSLA   422.80 (-1.86%)
NVDA   546.34 (+1.19%)
BABA   309.84 (+1.49%)
CGC   18.94 (-4.39%)
GE   7.31 (+0.27%)
MU   53.32 (+1.31%)
AMD   82.13 (+0.16%)
T   26.86 (-0.07%)
F   7.72 (+1.71%)
ACB   4.31 (-8.49%)
GILD   60.18 (-0.64%)
NFLX   526.50 (-0.80%)
BA   166.66 (-0.27%)
BAC   24.05 (+1.39%)
DIS   124.53 (+0.24%)
Log in
OTCMKTS:MMNFF

MedMen Enterprises Stock Forecast, Price & News

$0.12
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.12
Now: $0.12▼
$0.13
50-Day Range
$0.12
MA: $0.15▼
$0.22
52-Week Range
$0.09
Now: $0.12▼
$1.43
Volume3.62 million shs
Average Volume2.36 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 33 retail stores in nine states. The company was founded in 2010 and is headquartered in Culver City, California.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 3.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.36 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MMNFF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.medmen.com
Phone855-292-8399
Employees1,000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$0.12
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMNFF News and Ratings via Email

Sign-up to receive the latest news and ratings for MMNFF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedMen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions

How has MedMen Enterprises' stock price been impacted by COVID-19?

MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MMNFF stock has decreased by 21.2% and is now trading at $0.1213.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of MedMen Enterprises?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for MedMen Enterprises.

What guidance has MedMen Enterprises issued on next quarter's earnings?

MedMen Enterprises updated its first quarter 2021 After-Hours earnings guidance on Friday, October, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $60.245-60.245 million.

What price target have analysts set for MMNFF?

4 brokerages have issued 1-year target prices for MedMen Enterprises' shares. Their forecasts range from $0.75 to $4.00. On average, they expect MedMen Enterprises' stock price to reach $2.38 in the next twelve months. This suggests a possible upside of 1,858.0% from the stock's current price.
View analysts' price targets for MedMen Enterprises.

Are investors shorting MedMen Enterprises?

MedMen Enterprises saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 4,285,000 shares, a decline of 44.5% from the August 31st total of 7,713,800 shares. Based on an average daily trading volume, of 2,716,600 shares, the days-to-cover ratio is currently 1.6 days.
View MedMen Enterprises' Short Interest.

Who are some of MedMen Enterprises' key competitors?

Some companies that are related to MedMen Enterprises include (TGIF) (TGIF), (THCX.V) (THCX), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group Holdings Limited (AGH.AX) (AGH), Applied Biosciences (APPB), Auscann Group (AC8), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), Cannpal Animal Therapeutics (CP1) and Cansortium (CNTMF).
View all competitors.

Who are MedMen Enterprises' key executives?

MedMen Enterprises' management team includes the following people:
  • Mr. Benjamin Rose, Exec. Chairman (Age 46, Pay $62.5k)
  • Mr. Adam Nathaniel Bierman, Co-Founder (Age 39, Pay $1.15M)
  • Mr. Zeeshan Hyder, Chief Financial Officer (Age 33, Pay $541.56k)
  • Mr. Mike Lane, Chief Information Officer (Age 49, Pay $253.72k)
  • Mr. Thomas Jerome Lynch, Interim CEO & Chief Restructuring Officer (Age 52)

What is MedMen Enterprises' stock symbol?

MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."

How do I buy shares of MedMen Enterprises?

Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MedMen Enterprises' stock price today?

One share of MMNFF stock can currently be purchased for approximately $0.12.

What is MedMen Enterprises' official website?

The official website for MedMen Enterprises is www.medmen.com.

How can I contact MedMen Enterprises?

The company can be reached via phone at 855-292-8399.

This page was last updated on 10/20/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.